Enhancing systems medicine beyond genotype data by dynamic patient signatures: Having information and using it too

Frontiers in Genetics

Volumn 4, Issue , 2013, Pages 1-7

  Emmert Streib, Frank ^a   Dehmer, Matthias ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY FOR HEALTH SCIENCES   (Austria)

Author keywords

DynOmics data; Genome medicine; High throughput data; Next generation sequencing data; Personalized medicine

Indexed keywords

BIOLOGY; GENOME; GENOTYPE; HUMAN; HUMAN TISSUE; NEXT GENERATION SEQUENCING; PATHOLOGY; PATIENT CARE; PERSONALIZED MEDICINE; TRANSLATIONAL RESEARCH;

EID: 84991277765     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00241     Document Type: Article

References (94)

1. Abatangelo, L., Maglietta, R., Distaso, A., D'Addabbo, A., Creanza, T., Mukherjee, S., et al. (2009). Comparative study of gene set enrichment methods. BMC Bioinformatics 10:275. doi: 10.1186/1471-2105-10-275.
2. Ahn, A. C., Tewari, M., Poon, C.-S., and Phillips, R. S. (2006). The limits of reductionism in medicine: could systems biology offer an alternative? PLoS Med. 3:e208. doi: 10.1371/journal.pmed.0030208.
3. Alkan, C., Kidd, J.M.,Marques-Bonet, T., Aksay, G., Antonacci, F.,Hormozdiari, F., et al. (2009). Personalized copy number and segmental duplication maps using next-generation sequencing. Nat. Genet. 41, 1061-1067. doi: 10.1038/ng.437.
4. Ansorge, W. (2009). Next-generation dna sequencing techniques. New Biotechnol. 25, 195-203. doi: 10.1016/j.nbt.2008.12.009.
5. Arrell, D. K., and Terzic, A. (2010). Network systems biology for drug discovery. Clin. Pharmacol. Ther. 88, 120-125. doi: 10.1038/clpt.2010.91.
6. Ballestar, E., and Esteller, M. (2008). "Chapter 9 epigenetic gene regulation in cancer," in Long-Range Control of Gene Expression, Vol. 61 of Advances in Genetics, eds V. van Heyningen and R. E. Hill (Boston, MA: Academic Press), 247-267.
7. Baylin, S. B. (2005). Dna methylation and gene silencing in cancer. Nat. Clin. Pract. Oncol. 2(Suppl. 1), S4-S11. doi: 10.1038/ncponc0354.
8. Belcastro, V., Siciliano, V., Gregoretti, F., Mithbaokar, P., Dharmalingam, G., Berlingieri, S. et al. (2011). Transcriptional gene network inference from a mas- sive dataset elucidates transcriptome organization and gene function. Nucleic Acids Res. 39, 8677-8688. doi: 10.1093/nar/gkr593.
9. Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., et al. (2010). The landscape of somatic copy-number alteration across human cancers. Nature 463, 899-905. doi: 10.1038/nature08822.
10. Butte, A. J. (2008). Translational bioinformatics: coming of age. J. Am. Med. Inf. Assoc. 15, 709-714. doi: 10.1197/jamia.M2824.
11. Chan, I. S., and Ginsburg, G. S. (2011). Personalized medicine: progress and promise. Annu. Rev. Genomics Hum. Genet. 12, 217-244. doi: 10.1146/annurev-genom-082410-101446.
12. Chen, R.,Mias, G. I., Li-Pook-Than, J., Jiang, L., Lam, H. Y., Chen, R., et al. (2012). Personal omics pro?ling reveals dynamic molecular and medical phenotypes. Cell 148, 1293-1307. doi: 10.1016/j.cell.2012.02.009.
13. Chin, L., Andersen, J. N., and Futreal, P. A. (2011). Cancer genomics: from discovery science to personalized medicine. Nat. Med. 17, 297-303. doi: 10.1038/nm.2323.
14. Clarke, B., Fokoue, E., and Zhang, H. H. (2009). Principles and Theory for Data Mining and Machine Learning. Dordrecht; New York: Springer. doi: 10.1007/978-0-387-98135-2.
15. Collins, F. S., Guyer,M. S., and Chakravarti, A. (1997). Variations on a theme: cata- loging human dna sequence variation. Science 278, 1580-1581. doi: 10.1126/science.278.5343.1580.
16. Consortium, International Human Genome Sequencing (2004). Finishing the euchromatic sequence of the human genome. Nature 431, 931-945. doi:10.1038/nature03001.
17. Dawson,M. A., and Kouzarides, T. (2012). Cancer epigenetics: from mechanism to therapy. Cell 150, 12-27. doi: 10.1016/j.cell.2012.06.013.
18. de Matos Simoes, R., Dehmer, M., and Emmert-Streib, F. (2013). Interfacing cellular networks of S. cerevisiae and E. coli: connecting dynamic and genetic information. BMC Genomics 14:324. doi: 10.1186/1471-2164-14-324.
19. Djupedal, I., and Ekwall, K. (2009). Epigenetics: heterochromatinmeets RNAi. Cell Res. 19, 282-295. doi: 10.1038/cr.2009.13.
20. Egger, G., Liang, G., Aparicio, A., and Jones, P. A. (2004). Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-463. doi: 10.1038/nature02625.
21. Ehrlich,M., Gama-Sosa,M. A., Huang, L.-H.,Midgett, R.M., Kuo, K. C.,McCune, R. A., et al. (1982). Amount and distribution of 5-methylcytosine in human dna from different types of tissues or cells. Nucleic Acids Res. 10, 2709-2721. doi: 10.1093/nar/10.8.2709.
22. Emmert-Streib, F. (2013). Influence of the experimental design of gene expression studies on the inference of gene regulatory networks: environmental factors. PeerJ 1, e10. doi: 10.7717/peerj.10.
23. Emmert-Streib, F., and Dehmer, M. (2011). Networks for systems biology: conceptual connection of data and function. IET Syst. Biol. 5, 185. doi: 10.1049/iet- syb.2010.0025.
24. Emmert-Streib, F., and Glazko, G. (2011). Pathway analysis of expression data: deciphering functional building blocks of complex diseases. PLoS Comput. Biol. 7:e1002053. doi: 10.1371/journal.pcbi.1002053.
25. Emmert-Streib, F., Glazko, G., Altay, G., and de Matos Simoes, R. (2012a). Statistical inference and reverse engineering of gene regulatory networks from observational expression data. Front. Genet. 3:8. doi: 10.3389/fgene.2012.00008.
26. Emmert-Streib, F., Tripathi, S., and de Matos Simoes, R. (2012b). Harnessing the complexity of gene expression data from cancer: from single gene to structural pathway methods. Biol. Dir. 7, 44. doi: 10.1186/ 1745-6150-7-44.
27. Falconer, D. S., and Mackay, T. F. C. (1996). Introduction to Quantitative Genetics. Harlow: Longmans Green.
28. Fernald, G. H., Capriotti, E., Daneshjou, R., Karczewski, K. J., and Altman, R. B. (2011). Bioinformatics challenges for personalized medicine. Bioinformatics 27, 1741-1748. doi: 10.1093/bioinformatics/btr295
29. Förster, J., Famili, I., Fu, P., Palsson, B., and Nielsen, J. (2003). Genome-scale recon- struction of the Saccharomyces cerevisiae metabolic network. Genome Res. 13, 244-253. doi: 10.1101/gr.234503.
30. Freeman, J. L., Perry, G. H., Feuk, L., Redon, R., McCarroll, S. A., Altshuler, D. M., et al. (2006). Copy number variation: new insights in genome diversity. Genome Res. 16, 949-961. doi: 10.1101/gr.3677206.
31. Garbett, K., Ebert, P. J., Mitchell, A., Lintas, C., Manzi, B., Mirnics, K., et al. (2008). Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobio. Dis. 30, 303-311. doi: 10.1016/j.nbd.2008.01.012.
32. Ge, Y., Dudoit, S., and Speed, T. (2003). Resampling-based multiple testing for microarray data analysis. TEST 12, 1-77. doi: 10.1007/BF02595811.
33. Ghosh, D., and Poisson, L. M. (2009). 'Omics' data and levels of evidence for biomarker discovery. Genomics 93, 13-16. doi: 10.1016/j.ygeno.2008.07.006.
34. Ghosh, S., and Basu, A. (2012). Network medicine in drug design: impli- cations for neuroin?ammation. Drug Discov. Today 17, 600-607. doi: 10.1016/j.drudis.2012.01.018.
35. Hecht, S. S. (2003). Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. Cancer 3, 733-744. doi: 10.1038/nrc1190.
36. Highnam, G., andMittelman,D. (2012). Personal genomes and precisionmedicine. Genome Biol. 13, 324. doi: 10.1186/gb-2012-13-12-324.
37. Hopkins, A. L. (2008). Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 4, 682-690. doi: 10.1038/nchembio.118.
38. Huang, H., Liu, C.-C., and Zhou, X. J. (2010). Bayesian approach to transforming public gene expression repositories into disease diagnosis databases. Proc. Natl. Acad. Sci. U.S.A. 107, 6823-6828. doi: 10.1073/pnas.0912043107.
39. Izenman, A. J. (2008). Modern Multivariate Statistical Techniques.NewYork,NY: Springer. doi: 10.1007/978-0-387-78189-1.
40. Kresse, S. H., Ohnstad, H. O., Bjerkehagen, B., Myklebost, O., and Meza-Zepeda, L. A. (2010). DNA copy number changes in human malignant fibrous histiocy tomas by array comparative genomic hybridisation. PLoS ONE 5:e15378. doi: 10.1371/journal.pone.0015378.
41. LaFramboise, T. (2009). Single nucleotide polymorphism arrays: a decade of biological, computational and technological advances. Nucleic Acids Res. 37, 4181-4193. doi: 10.1093/nar/gkp552.
42. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., et al. (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921. doi: 10.1038/35057062.
43. Law, J. A., and Jacobsen, S. E. (2010). Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat. Rev. Genet. 11, 204-220. doi: 10.1038/nrg2719.
44. Lee, T. I., Rinaldi, N. J., Robert, F., Odom, D. T., Bar-Joseph, Z., Gerber, G. K., et al. (2002). Transcriptional regulatory networks in Saccharomyces cerevisiae. Science 298, 799-804. doi: 10.1126/science.1075090.
45. Leung, E. L., Cao, Z.-W., Jiang, Z.-H., Zhou, H., and Liu, L. (2012). Network-based drug discovery by integrating systems biology and computational technologies. Brief. Bioinform. 14, 491-505. doi: 10.1093/bib/bbs043.
46. Lussier, Y. A., Butte, A. J., and Hunter, L. (2010). Guest editorial: current method- ologies for translational bioinformatics. J. Biomed. Inform. 43, 355-357. doi: 10.1016/j.jbi.2010.05.002.
47. Lynch, M., and Walsh, B. (1998). Genetics and Analysis of Quantitative Traits, Sinauer: Sunderland.
48. Madhamshettiwar, P., Maetschke, S., Davis, M., Reverter, A., and Ragan, M. (2012). Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drugtargets. Genome Med. 4, 41. doi: 10.1186/gm340.
49. Manolio, T. A. (2010). Genomewide association studies and assessment of the risk of disease. NewEng.J.Med. 363, 166-176. doi: 10.1056/NEJMra0905980.
50. Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., et al. (2009). Finding the missing heritability of complex diseases. Nature 461, 747-753. doi: 10.1038/nature08494.
51. Mardis, E. R. (2008). Next-generation dna sequencing methods. Annu. Rev. Genomics Hum. Genet. 9, 387-402. doi: 10.1146/annurev.genom.9.081307. 164359.
52. McCarroll, S. A., and Altshuler, D. M. (2007). Copy-number variation and asso- ciation studies of human disease. Nat. Genet. 39 (Suppl. 7), S37-S42. doi: 10.1038/ng2080.
53. McCarthy, M., Abecasis, G., Cardon, L., Goldstein, D., Little, J., Ioannidis, J., et al. (2008). Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9, 356-369. doi: 10.1038/nrg2344.
54. Metzker, M. (2009). Sequencing technologies-the next generation. Nat. Rev. Genet. 11, 31-46. doi: 10.1038/nrg2626.
55. Moreno-Risueno,M. A., Busch,W., and Benfey, P. N. (2010). Omicsmeet networks - using systems approaches to infer regulatory networks in plants, Curr. Opin. Plant Biol. 13, 126-131. doi: 10.1016/j.pbi.2009.11.005.
56. Moss, T. J., andWallrath, L. L. (2007). Connections between epigenetic gene silenc- ing and human disease.Mutat. Res. Fundam.Mol.Mech.Mutagen. 618, 163-174. doi: 10.1016/j.mrfmmm.2006.05.038.
57. Murthy, S. S., and Testa, J. R. (1999). Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma. J. Cell. Physiol. 180, 150-157. doi: 10.1002/(SICI)1097-4652(199908)180:2<150::AID-JCP2>3.0.CO;2.H.
58. Ng, P. C.,Murray, S. S., Levy, S., and Venter, J. C. (2009). An agenda for personalized medicine. Nature 461, 724-726. doi: 10.1038/461724a.
59. Noble, D. (2008). Genes and causation. Phil. Trans. R. Soc. A 366, 3001-3015. doi: 10.1098/rsta.2008.0086.
60. Ostrowski, J., and Wyrwicz, L. S. (2009). Integrating genomics, proteomics and bioinformatics in translational studies of molecular medicine. Exp. Rev. Mol. Diagn. 9, 623-630. doi: 10.1586/erm.09.41.
61. Oti, M., Snel, B., Huynen, M., and Brunner, H. (2006). Predicting disease genes using protein-protein interactions. J. Med. Genet. 43, 691-698. doi: 10.1136/jmg.2006.041376.
62. Palsson, B. (2006). Systems Biology, Cambridge; NewYork: CambridgeUniversity Press. doi: 10.1017/CBO9780511790515.
63. Pearson, T., and Manolio, T. (2008). How to interpret a genome-wide association study. JAMA 299, 1335-1344. doi: 10.1001/jama.299.11.1335.
64. Pinto, D., Darvishi, K., Shi, X., Rajan, D., Rigler, D., Fitzgerald, T., et al. (2011). Comprehensive assessment of array-based platforms and calling algo- rithms for detection of copy number variants. Nat. Biotech. 29, 512-520. doi: 10.1038/nbt.1852.
65. Richardson, B. C. (2002). Role of dnamethylation in the regulation of cell function: autoimmunity, aging and cancer. J. Nutr. 132, 2401S-2405S.
66. Robertson, K. D. (2005). DNA methylation and human disease. Nat. Rev. Genet. 6, 597-610. doi: 10.1038/nrg1655.
67. Romero, R., Espinoza, J., Gotsch, F., Kusanovic, J., Friel, L., Erez, O., et al. (2006). The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome. BJOG Int. J. Obstet. Gynaecol. 113, 118-135. doi: 10.1111/j.1471-0528.2006.01150.x.
68. Rual, J.-F., Venkatesan, K., Hao, T., and Hirozane-Kishikawa, T. (2005). Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173-1178. doi: 10.1038/nature04209.
69. Sachidanandam, R., Weissman, D., Schmidt, S. C., Kakol, J. M., Stein, L. D., Marth, G., et al. (2001). A map of human genome sequence variation containing 1.42. million single nucleotide polymorphisms. Nature 409, 928-933. doi: 10.1038/35057149.
70. Sassone-Corsi, P., Imhof, A., and Katada, S. (2012). Connecting threads: epigenetics and metabolism. Cell 148, 24-28. doi: 10.1016/j.cell.2012.01.001.
71. Sechi, S., (ed). (2007). Quantitative Proteomics by Mass Spectrometry. (Totowa, NJ: Humana Press). doi: 10.1007/978-1-59745-255-7.
72. Shendure, J., and Ji, H. (2008). Next-generation dna sequencing. Nat. Biotechnol. 26, 1135-1145. doi: 10.1038/nbt1486.
73. Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., et al. (2007). A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881-885. doi: 10.1038/nature05616.
74. Soffritti, M., Maltoni, C., Maffei, F., and Biagi, R. (1989). Formaldehyde: an experimental multipotential carcinogen. Toxicol. Indust. Health 5, 699-730. doi: 10.1177/074823378900500510.
75. Speed, T. (2003). Statistical Analysis of Gene Expression Microarray Data. Boca Raton, FL: Chapman and Hall/CRC. doi: 10.1201/9780203011232.
76. Stelzl, U., Worm, U., Lalowski, M., Haenig, C., Brembeck, F., Goehler, H., et al. (2005). A human protein-protein interaction network: a resource for annotating the proteome. Cell 122, 957-968. doi: 10.1016/j.cell.2005.08.029.
77. Stepanov, V. A. (2010). Genomes, populations and diseases: eth- nic genomics and personalized medicine. Acta Nat. 2, 15-30. Available online at: http://www.ncbi.nlm.nih.gov/pubmed/?term=%22Genomes%2C+populations+and+diseases%3A+ethnic+genomics+and+653+personalized+medicine%22.
78. Stephens, P. J.,McBride, D. J., Lin, M.-L., Varela, I., Pleasance, E. D., Simpson, J. T., et al. (2009). Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462, 1005-1010. doi: 10.1038/nature08645.
79. Storey, J., and Tibshirani, R. (2003). Statistical signi?cance for genomewide studies. Proc. Natl. Acad. Sci. U.S.A. 100, 9440-9445. doi: 10.1073/pnas. 1530509100.
80. Subramanian, A., Tamayo, P., Mootha, V., Mukherjee, S., Ebert, B., Gillette, M., et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545-15550. doi: 10.1073/pnas.0506580102.
81. The ENCODE Project Consortium (2011). A user's guide to the encyclopedia of DNA elements (eNCODE). PLoS Biol. 9:e1001046. doi: 10.1371/jour- nal.pbio.1001046.
82. Tripathi, S., and Emmert-Streib, F. (2012). Assessment method for a power analysis to identify differentially expressed pathways. PLoS ONE 7:e37510. doi: 10.1371/journal.pone.0037510.
83. Turner, B. M. (2007). Defining an epigenetic code. Nat. Cell Biol. 9, 2-6. doi: 10.1038/ncb0107-2.
84. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., et al. (2001). The sequence of the human genome. Science 291, 1304-1351. doi: 10.1126/science.1058040.
85. Wang, Z., Gerstein, M., and Snyder, M. (2009). RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57-63. doi: 10.1038/nrg2484.
86. Welch, B. M., and Kawamoto, K. (2012). Clinical decision support for genetically guided personalized medicine: a systematic review. J. Am. Med. Inform. Assoc. 20, 388-400. doi: 10.1136/amiajnl-2012-000892.
87. Werner, T. (2010). Next generation sequencing in functional genomics. Brief. Bioinformat. 11, 499-511. doi: 10.1093/bib/bbq018.
88. Wheeler, D. L., Barrett, T., Benson, D. A., Bryant, S. H., Canese, K., Chetvernin, V., et al. (2007). Database resources of the national center for biotechnology information. Nucleic Acids Res. 35 (Suppl. 1), D5-D12. doi: 10.1093/nar/gkl1031.
89. Wu, X., Jiang, R., Zhang, M. Q., and Li, S. (2008). Network-based global inference of human disease genes. Mol. Syst. Biol. 4, 189. doi: 10.1038/msb.2008.27.
90. Yang, P., Li, X., Wu, M., Kwoh, C.-K., and Ng, S.-K. (2011). Inferring gene phenotype associations via global protein complex network propagation, PLoS ONE 6:e21502. doi:10.1371/journal.pone.0021502.
91. Yeager,M., Orr, N., Hayes, R. B., Jacobs, K. B., Kraft, P.,Wacholder, S., et al. (2007). Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39, 645-649. doi: 10.1038/ng2022.
92. Yu, H., Braun, P., Yildirim, M. A., Lemmens, I., Venkatesan, K., Sahalie, J., et al. (2008). High-quality binary protein interaction map of the yeast interactome network. Science 322, 104-110. doi: 10.1126/science.1158684.
93. Zhang, J., Chiodini, R., Badr, A., and Zhang, G. (2011). The impact of next generation sequencing on genomics. J. Genet. Genomics 38, 95-109. doi: 10.1016/j.jgg.2011.02.003.
94. Ziegler, A., Koch, A., Krockenberger, K., and Grosshennig, A. (2012). Personalized medicine using dna biomarkers: a review. Hum. Genet. 131, 1627-1638. doi: 10.1007/s00439-012-1188-9.